-
Part 1 | Session 7 Summary of ReCross versatility in ADR summary (7mins 29secs)
-
Part 2 | Session 3 Clinical ADR experience with ReCross in CTO PCI: Dr Smith (21mins 31secs)
-
Part 2 | Session 12 My personal experience of ReCross versatility: Dr Garbo (19mins 56secs)
-
Part 3 | Session 1 ReCross within my CTO algorithm: Dr McEntegart (21mins 11secs)
-
Part 1 | Session 1 How-to-use ReCross video Dr Avran (2mins 55secs)
-
Part 1 | Session 2 Official IMDS ReCross How-to-Use Video (4mins 12secs)
-
Part 1 | Session 3 How ReCross Modified My CTO Strategies: Dr Avran (16mins 46secs)
-
Part 1 | Session 5 Exit port orientation- easy tips: Dr Lucking (2mins 12secs)
Through the case experience of an international faculty of CTO PCI experts, the emerging understanding of the everyday efficiency of the unique ReCross dual OTW lumen microcatheter is demonstrated.
The experts consider their personal CTO PCI algorithms, and how they believe ReCross’s versatility allows the device to contribute to antegrade success in the widely recognised EuroCTO Club and Hybrid algorithms respectively.

Key Learning Objectives
- Understand the versatility of the unique ReCross dual OTW microcatheter in CTO PCI
- Discover, via case demonstrations, how the ReCross device creates a bridge between commonly used CTO PCI algorithms, for example EuroCTO and Hybrid
- Learn from CTO PCI experts how, in their experience, there is a potential to increase antegrade success rates with this device
- Learn how the accessible versatility of ReCross has the potential role for operators expanding their skill set from Antegrade Wire Escalation to parallel wiring and ADR
Faculty
- Dr Farouc Jaffer
- Dr Alexandre Avran
- Dr Andrew Lucking
- Dr Emmanouil Brilakis
- Dr Elliot Smith
- Dr Roberto Garbo
- Dr Ajay Kirtane
- Dr Margaret McEntegart
- Dr Gabriele Gasparini
More from this programme
Part 1
When Two Worlds Meet 1
Part 2
When Two Worlds Meet 2
Faculty Biographies
Farouc Jaffer
Director, Coronary Intervention
Dr Jaffer is Associate Professor of Medicine at Harvard Medical School and an Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at Massachusetts General Hospital.
Dr Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.